A review on pharmacological activity of Terminalia chebula

---

Review Article

Author Details : Aparajita Gupta*, Sachin Pandey

Volume : 9, Issue : 3, Year : 2022

Article Page : 153-159

https://doi.org/10.18231/j.ijmr.2022.028

Suggest article by email

Get Permission

---

Abstract

Since the beginning of civilization, people have used medicinal herbs to treat illnesses. Medicinal plants, which are valued as plentiful sources of folk medicine, are the source of many contemporary pharmaceuticals. T. chebula is used in several ayurvedic formulations and may have therapeutic benefits. Terminalia chebula Retz. (Family Combretaceae) is frequently at the top of the list of "Ayurvedic Materia Medica" and is referred to as the "King of Medicine" in Tibet due to its exceptional healing abilities, popularly referred to as "Harar". The entire plant is very restorative and has historically been used to treat a variety of human illnesses. Folklore claims that this plant was used to heal a variety of ailments, including gout, asthma, sore throats, bleeding piles, ulcers, hiccoughs, diarrhoea, and dysentery. Numerous pharmacological and therapeutic actions of the plant have been identified, including anti-inflammatory, anti-mutagenic, anti-proliferative, radioprotective, cardioprotective, anti-arthritic, and qualities that increase gastrointestinal motility. We have looked into the phyto-pharmacological characteristics of the plant and compiled its varied pharmacological uses in this review in order to comprehend and synthesise
the issue of T. chebula potential role as a multifunctional therapeutic agent.

Keywords: Medicinal herbs, Terminalia chebula, Therapeutic agent, King of Medicine, Folk medicine.

How to cite : Gupta A, Pandey S, A review on pharmacological activity of Terminalia chebula. Indian J Microbiol Res 2022;9(3):153-159

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.